Research set to be presented in Los Angeles links hearing loss to type 2 diabetes, cognitive decline, and the growing GLP-1 medication landscape—underscoring hearing health’s expanding role in whole-body care. More than 5,000 otolaryngologists are expected to convene in Los Angeles Oct....
Continue reading at Hearing Review
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change at this time — findings are previewed conference abstracts and have not yet been presented or peer-reviewed; audiologists should monitor published outcomes post-meeting.
Positioning hearing loss within systemic conditions like diabetes and cognitive decline reinforces audiology's role in integrated, whole-person care and may drive interdisciplinary referral pathways.
- 01AAO-HNSF 2026 Annual Meeting takes place October 17–20 in Los Angeles, California.
- 02Upcoming research links hearing loss to type 2 diabetes and cognitive decline.
- 03GLP-1 medications (a class of drugs used for diabetes and weight loss) are a new focus area in hearing health research.
- 04The meeting signals growing recognition of hearing health as a systemic health issue.
- 05Findings are pre-publication conference previews; peer-reviewed evidence is pending.
Hearing loss is linked to type 2 diabetes.
studypartially supportedHearing loss is linked to cognitive decline.
studypartially supportedGLP-1 medications have a relationship with hearing health.
studyunclear